147 related articles for article (PubMed ID: 9374501)
1. Analysis of the human factor VIII A2 inhibitor epitope by alanine scanning mutagenesis.
Lubin IM; Healey JF; Barrow RT; Scandella D; Lollar P
J Biol Chem; 1997 Nov; 272(48):30191-5. PubMed ID: 9374501
[TBL] [Abstract][Full Text] [Related]
2. Residues 484-508 contain a major determinant of the inhibitory epitope in the A2 domain of human factor VIII.
Healey JF; Lubin IM; Nakai H; Saenko EL; Hoyer LW; Scandella D; Lollar P
J Biol Chem; 1995 Jun; 270(24):14505-9. PubMed ID: 7540171
[TBL] [Abstract][Full Text] [Related]
3. The diversity of the immune response to the A2 domain of human factor VIII.
Markovitz RC; Healey JF; Parker ET; Meeks SL; Lollar P
Blood; 2013 Apr; 121(14):2785-95. PubMed ID: 23349389
[TBL] [Abstract][Full Text] [Related]
4. Analysis of factor VIII inhibitors using hybrid human/porcine factor VIII.
Lollar P
Thromb Haemost; 1997 Jul; 78(1):647-51. PubMed ID: 9198232
[TBL] [Abstract][Full Text] [Related]
5. Epitope mapping of human factor VIII inhibitor antibodies by site-directed mutagenesis of a factor VIII polypeptide.
Ware J; MacDonald MJ; Lo M; de Graaf S; Fulcher CA
Blood Coagul Fibrinolysis; 1992 Dec; 3(6):703-16. PubMed ID: 1283342
[TBL] [Abstract][Full Text] [Related]
6. Reduction of the antigenicity of factor VIII toward complex inhibitory antibody plasmas using multiply-substituted hybrid human/porcine factor VIII molecules.
Barrow RT; Healey JF; Gailani D; Scandella D; Lollar P
Blood; 2000 Jan; 95(2):564-8. PubMed ID: 10627463
[TBL] [Abstract][Full Text] [Related]
7. Frequency and epitope specificity of anti-factor VIII C1 domain antibodies in acquired and congenital hemophilia A.
Kahle J; Orlowski A; Stichel D; Healey JF; Parker ET; Jacquemin M; Krause M; Tiede A; Schwabe D; Lollar P; Königs C
Blood; 2017 Aug; 130(6):808-816. PubMed ID: 28507083
[TBL] [Abstract][Full Text] [Related]
8. Antigenicity of putative phospholipid membrane-binding residues in factor VIII.
Barrow RT; Healey JF; Jacquemin MG; Saint-Remy JM; Lollar P
Blood; 2001 Jan; 97(1):169-74. PubMed ID: 11133757
[TBL] [Abstract][Full Text] [Related]
9. Epitope mapping via selection of anti-FVIII antibody-specific phage-presented peptide ligands that mimic the antibody binding sites.
Kahle J; Orlowski A; Stichel D; Becker-Peters K; Kabiri A; Healey JF; Brettschneider K; Naumann A; Scherger AK; Lollar P; Schwabe D; Königs C
Thromb Haemost; 2015 Feb; 113(2):396-405. PubMed ID: 25520269
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain.
van den Brink EN; Turenhout EA; Bank CM; Fijnvandraat K; Peters M; Voorberg J
Blood; 2000 Jul; 96(2):540-5. PubMed ID: 10887116
[TBL] [Abstract][Full Text] [Related]
11. Anti-factor VIII inhibitor alloantibodies recognizing the A2 domain in the human factor VIII heavy chain poorly bind to porcine factor VIII.
Sawamoto Y; Shima M; Tanaka I; Nakai H; Kamisue S; Scandella D; Yoshioka A
Int J Hematol; 1997 Feb; 65(2):151-8. PubMed ID: 9071819
[TBL] [Abstract][Full Text] [Related]
12. Residues Glu2181-Val2243 contain a major determinant of the inhibitory epitope in the C2 domain of human factor VIII.
Healey JF; Barrow RT; Tamim HM; Lubin IM; Shima M; Scandella D; Lollar P
Blood; 1998 Nov; 92(10):3701-9. PubMed ID: 9808564
[TBL] [Abstract][Full Text] [Related]
13. In hemophilia A and autoantibody inhibitor patients: the factor VIII A2 domain and light chain are most immunogenic.
Scandella DH; Nakai H; Felch M; Mondorf W; Scharrer I; Hoyer LW; Saenko EL
Thromb Res; 2001 Mar; 101(5):377-85. PubMed ID: 11297754
[TBL] [Abstract][Full Text] [Related]
14. The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups.
Prescott R; Nakai H; Saenko EL; Scharrer I; Nilsson IM; Humphries JE; Hurst D; Bray G; Scandella D
Blood; 1997 May; 89(10):3663-71. PubMed ID: 9160671
[TBL] [Abstract][Full Text] [Related]
15. Hybrid human-porcine factor VIII proteins partially escape the inhibitory effects of anti-factor VIII inhibitor alloantibodies having A2 or C2 domain specificity.
Mizumachi K; Nakajima Y; Shimonishi N; Furukawa S; Ogiwara K; Takeyama M; Nogami K
Haemophilia; 2024 Jan; 30(1):140-150. PubMed ID: 38058226
[TBL] [Abstract][Full Text] [Related]
16. The humoral response to human factor VIII in hemophilia A mice.
Healey JF; Parker ET; Barrow RT; Langley TJ; Church WR; Lollar P
J Thromb Haemost; 2007 Mar; 5(3):512-9. PubMed ID: 17181826
[TBL] [Abstract][Full Text] [Related]
17. High-resolution mapping of epitopes on the C2 domain of factor VIII by analysis of point mutants using surface plasmon resonance.
Nguyen PC; Lewis KB; Ettinger RA; Schuman JT; Lin JC; Healey JF; Meeks SL; Lollar P; Pratt KP
Blood; 2014 Apr; 123(17):2732-9. PubMed ID: 24591205
[TBL] [Abstract][Full Text] [Related]
18. Reduction of the inhibitory antibody response to human factor VIII in hemophilia A mice by mutagenesis of the A2 domain B-cell epitope.
Parker ET; Healey JF; Barrow RT; Craddock HN; Lollar P
Blood; 2004 Aug; 104(3):704-10. PubMed ID: 15073030
[TBL] [Abstract][Full Text] [Related]
19. A subset of high-titer anti-factor VIII A2 domain antibodies is responsive to treatment with factor VIII.
Eubanks J; Baldwin WH; Markovitz R; Parker ET; Cox C; Kempton CL; Meeks SL
Blood; 2016 Apr; 127(16):2028-34. PubMed ID: 26825708
[TBL] [Abstract][Full Text] [Related]
20. The comparative immunogenicity of human and porcine factor VIII in haemophilia A mice.
Healey JF; Parker ET; Barrow RT; Langley TJ; Church WR; Lollar P
Thromb Haemost; 2009 Jul; 102(1):35-41. PubMed ID: 19572065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
